Evasc is a medical device company focused on novel solutions for the endovascular repair of cerebral aneurysms, to provide a much higher standard of care and rate of successful treatment outcomes than previously possible.

Evasc’s first nitinol device, the eCLIPs Bifurcation Aneurysm Remodeling System, eBRS, shows superior clinical outcomes and an excellent safety profile.  Its successor, the electrolytic eCLIPs Bifurcation device, eB, is easier to deploy and compliant with generic smaller catheters.  eCLIPs technology is protected by multiple patents and is designed to treat 95% of cerebral aneurysms, including the most challenging wide-neck bifurcations.